HOWL Werewolf Therapeutics, Inc.
$0.98▲ +0.05%
Healthcare
Other
Volume 477.4K
Avg Volume (10D) 402.1K
Key Metrics & Fundamentals
Market Cap
$47.66M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.27 - 1.83
% vs 50 MA
6.91%
% vs 200 MA
45.81%
RSI-14
54.1
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.98
Free Cash Flow
$6.63M
Gross Rev
$21.00M
Gross Profit
$21.00M
EBITDA
$9.95M
COGS
–
Operating Exp
$13.84M
Operating Income
$7.16M
EBIT
$7.16M
Pretax Income
$3.67M
Net Income
$3.67M
EPS (Diluted)
0.08
Price & Volume History
Loading chart…
Recent News
Roche Gets FDA Approval for Enspryng in Thyroid Eye Disease
Zacks · Oct 16, 2026 10:21 AM ET
KRYS Reports Positive Early Data for KB113 in Gorlin Syndrome
Zacks · Oct 16, 2026 10:19 AM ET
Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's Why
Zacks · Oct 13, 2026 11:00 AM ET
TGTX Stock Rises 60% in 6 Months: Here's What You Should Know
Zacks · Oct 13, 2026 9:47 AM ET
Mirum's Livmarli Meets Phase III Goal in Ultra-Rare Liver Diseases
Zacks · Oct 13, 2026 9:41 AM ET
New Strong Buy Stocks for October 9th
Zacks · Oct 9, 2026 5:46 AM ET
HALO Expands ENHANZE Collaboration & Licensing Deal With ARGX
Zacks · Oct 7, 2026 9:58 AM ET
1 Penny Stock That Could Howl Its Way to the Top After a $150 Million Funding Boost
Barchart · Aug 26, 2026 11:47 AM ET
Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News
Barchart · Aug 21, 2026 1:51 PM ET
Sector Update: Healthcare Stocks Advance in Afternoon Trading
MT Newswires · Aug 21, 2026 1:43 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See HOWL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.